However, we observed that clinical data from patients diagnosed with testicular germ cell tumor, ovarian cancer, and lung squamous cell carcinoma indicated that low BUD31 expression was strongly associated with worse overall survival (OS) (as illustrated in Figure 2B–D). Here, BUD31 is linked to squamous cell lung carcinoma.